2022-003060-25
Open-label, multicenter, multinational, interventional Clinical Trial to assess Efficacy and Safety of the extemporaneous combination of Nebivolol and Ramipril in hypertensive patients - ARTEMISIA study
Menarini International Operations Luxembourg SA·EU Clinical Trials RegisterOngoing
Study focus
- Disease/Condition
- Cardiovascular Disease
Sponsor & location
- Primary sponsor
- Menarini International Operations Luxembourg SA
Timeline & enrollment
- Phase
- N/A
- Start date
- N/A
- End date
- N/A
Primary outcome
Any patient who meets any of the following criteria will not qualify for entry into the study:
ICD-10 classifications
Cardiovascular disease, unspecifiedHypertensive heart diseaseHeart disease, unspecifiedAtherosclerotic cardiovascular disease, so describedAtherosclerotic heart disease
Data source
- Registry
- EU Clinical Trials Register
- Trial ID
- 2022-003060-25
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for 2022-003060-25 through Pure Global AI's free database. This phase not specified trial is sponsored by Menarini International Operations Luxembourg SA and is currently Ongoing. The study focuses on Cardiovascular Disease.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to EU Clinical Trials Register data, helping medical device and pharmaceutical companies navigate clinical research efficiently.